Improved sexuality and satisfactory lubrication after genital affirmation surgery using penile skin inversion in transgender women: A satisfaction study.

Genital affirmation surgery Lubrication Penile skin inversion Squirting effect Transgender women sexuality Vaginoplasty

Journal

Journal of plastic, reconstructive & aesthetic surgery : JPRAS
ISSN: 1878-0539
Titre abrégé: J Plast Reconstr Aesthet Surg
Pays: Netherlands
ID NLM: 101264239

Informations de publication

Date de publication:
11 2023
Historique:
received: 06 02 2023
revised: 10 07 2023
accepted: 16 07 2023
medline: 6 11 2023
pubmed: 30 8 2023
entrez: 29 8 2023
Statut: ppublish

Résumé

Genital affirmation surgery (GAS) requests are consistently increasing in demand. The gold standard is penile skin inversion, using cutaneous grafting for neovagina creation. The aim is to achieve the most realistic results both physically and functionally. Different studies have contradictory results, and the use of lubrication is insufficiently clear, while the use of sigmoidoplasty has been defended for constant lubrication. Our aim was to evaluate transgender women's sexual function and lubrication after vaginoplasty by penile skin inversion. We performed a prospective study on 45 patients who underwent primary penile inversion vaginoplasty. Participants answered two questionnaires during the follow-up consultation: the Female Sexual Function Index (FSFI) and an 18-item custom questionnaire. The average FSFI score of our patients was 28.9, up to the cut-off defining a sexual disorder. Compared to the Wylomanski control group, no differences were found for the FSFI score and in the subgroups. Considering lubrication, 69% of the patients were satisfied or very satisfied with their lubrication. Furthermore, 53% reported a fluid release at each orgasm. This study reported high satisfaction for both sexuality and lubrication, proning against penile inversion's GAS bad reputation concerning postoperative lubrication. A squirting effect was described for the first time and was present in 53% of our transpatients.

Identifiants

pubmed: 37643527
pii: S1748-6815(23)00432-1
doi: 10.1016/j.bjps.2023.07.024
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-14

Informations de copyright

Copyright © 2023 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflict of interest to declare.

Auteurs

Lorraine Litrico (L)

Department of Plastic Surgery, Sorbonne University, Paris, France; Institut national de la santé et de la recherche médicale 1148, Laboratoire de recherche vasculaire translationnelle, Bichat Hospital, Paris City University, France. Electronic address: lorraine.litrico@aphp.fr.

Loïc Van Dieren (L)

Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.

Curtis L Cetrulo (CL)

Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America; Plastic and reconstructive surgery department, Massachusetts General Hospital, Boston, MA, United States of America; Department of Plastic Surgery, Shriners Hospital for Children, Boston, MA, United States of America.

Michael Atlan (M)

Department of Plastic Surgery, Sorbonne University, Paris, France.

Alexandre G Lellouch (AG)

Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America; Plastic and reconstructive surgery department, Massachusetts General Hospital, Boston, MA, United States of America; Department of Plastic Surgery, Shriners Hospital for Children, Boston, MA, United States of America; Department of Plastic, Reconstructive and Aesthetic Surgery, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Sarra Cristofari (S)

Department of Plastic Surgery, Sorbonne University, Paris, France; Institut national de la santé et de la recherche médicale 1148, Laboratoire de recherche vasculaire translationnelle, Bichat Hospital, Paris City University, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH